Search Results - "Gown, Allen M."
-
1
Current issues in ER and HER2 testing by IHC in breast cancer
Published in Modern pathology (01-05-2008)“…The presence of estrogen receptors (ERs), as detected by immunohistochemistry (IHC), is a weak prognostic marker of clinical outcome in breast cancer, but a…”
Get full text
Journal Article -
2
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group
Published in Archives of pathology & laboratory medicine (1976) (01-01-2018)“…- Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. - To provide updated, practical guidelines for the pathologic diagnosis…”
Get full text
Journal Article -
3
BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
Published in The American journal of surgical pathology (01-07-2015)“…A variety of immunohistochemical (IHC) stains have been proposed to mark either benign or malignant mesothelial proliferations. Loss of the p16 tumor…”
Get full text
Journal Article -
4
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens
Published in The American journal of surgical pathology (01-01-2016)“…The diagnosis of malignant mesothelioma in effusion cytology specimens is controversial. BAP1 immunohistochemistry and p16 fluorescence in situ hybridization…”
Get full text
Journal Article -
5
BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas
Published in The American journal of surgical pathology (01-05-2016)“…The separation of sarcomatous and desmoplastic mesotheliomas from benign organizing pleuritis can be morphologically very difficult. Deletion of p16 (CDKN2A)…”
Get full text
Journal Article -
6
Markers of metastatic carcinoma of breast origin
Published in Histopathology (01-01-2016)“…This review summarizes the three major breast‐associated markers that can be of assistance in evaluating metastatic carcinomas for which a breast primary…”
Get full text
Journal Article -
7
Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
Published in The American journal of surgical pathology (01-12-2010)“…The histologic subtype of non-small cell lung carcinoma is important in selecting appropriate chemotherapy for patients with advanced disease. As many of these…”
Get full text
Journal Article -
8
An international study to increase concordance in Ki67 scoring
Published in Modern pathology (01-06-2015)“…Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limited its clinical use. Our previous study found variability…”
Get full text
Journal Article -
9
Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
Published in Journal of clinical oncology (10-12-2008)“…Human epidermal growth factor receptor 2 gene (HER2) is associated with a poorer outcome in node-positive breast cancer, but the results are conflicting in…”
Get full text
Journal Article -
10
Thyroid Transcription Factor-1 Expression in Breast Carcinomas
Published in The American journal of surgical pathology (01-12-2010)“…Immunostaining for thyroid transcription factor-1 (TTF-1) is frequently used to help assess the site of origin of metastatic carcinomas. TTF-1 expression is…”
Get full text
Journal Article -
11
IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations
Published in The American journal of surgical pathology (01-03-2013)“…Distinguishing malignant mesotheliomas from benign mesothelial proliferations on hematoxylin and eosin-stained sections can be extremely challenging. Various…”
Get full text
Journal Article -
12
Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy
Published in Journal of clinical oncology (01-11-2011)“…The ratio of human epidermal growth factor receptor 2 (HER2) to CEP17 by fluorescent in situ hybridization (FISH) with the centromeric probe CEP17 is used to…”
Get full text
Journal Article -
13
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
Published in Clinical cancer research (15-08-2004)“…Purpose: Expression profiling studies classified breast carcinomas into estrogen receptor (ER)+/luminal, normal breast-like, HER2 overexpressing, and…”
Get full text
Journal Article -
14
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group
Published in Archives of pathology & laboratory medicine (1976) (01-08-2009)“…Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. To develop practical guidelines for the pathologic diagnosis of MM. A…”
Get full text
Journal Article -
15
Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall
Published in Modern pathology (01-07-2008)“…Alveolar rhabdomyosarcoma may be extremely difficult to distinguish from other primitive round cell neoplasms without ancillary immunohistochemistry and/or…”
Get full text
Journal Article -
16
Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
Published in Journal of clinical oncology (01-10-2010)“…The optimal method to assess human epidermal growth factor receptor 2 (HER2) status remains highly controversial. Before reporting patient HER2 results,…”
Get full text
Journal Article -
17
Diagnostic Utility of Galectin-3 in Thyroid Cancer
Published in The American journal of pathology (01-05-2010)“…Galectin-3 (Gal-3), which has received significant recent attention for its utility as a diagnostic marker for thyroid cancer, represents the most well-studied…”
Get full text
Journal Article -
18
Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary : Analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases
Published in The American journal of surgical pathology (01-09-2006)“…Coordinate expression profiles for cytokeratins 7 and 20 (CK7 and CK20) are useful for distinguishing certain types of adenocarcinomas but use for distinction…”
Get full text
Journal Article -
19
Evaluation of Human Epidermal Growth Factor Receptor 2 (HER2) Gene Status in Human Breast Cancer Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Specimens by Fluorescence In Situ Hybridization (FISH)
Published in Methods in molecular biology (Clifton, N.J.) (2016)“…Current standard of care requires that HER2 gene testing be performed on all newly diagnosed invasive breast cancers in order to determine eligibility for…”
Get more information
Journal Article -
20
Improved Detection of Apoptotic Cells in Archival Paraffin Sections: Immunohistochemistry Using Antibodies to Cleaved Caspase 3
Published in The journal of histochemistry and cytochemistry (01-04-2002)“…Apoptosis has gained central importance in the study of many biological processes, including neoplasia, neurodegenerative diseases, and development. One of the…”
Get full text
Journal Article